Updated:
Indaco Capital
Indaco Capital is a venture capital firm based in China that focuses on healthcare investments. The firm has made 11 investments to date. Its most recent...
Indaco Capital
Indaco Capital is a venture capital firm based in China that focuses on healthcare investments. The firm has made 11 investments to date. Its most recent investment was in ReLive Biotechnologies as part of their Series A funding on January 25, 2023.
General information
Firm type
Venture Capital
Year founded
2015
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
What investment stages does Indaco Capital target?
Indaco targets seed and early-stage venture rounds in China. This means the firm typically enters at a company's first priced equity round or shortly after formation. The firm's official strategy is listed as seed and general venture, placing it at the earliest institutional entry point before larger multi-stage funds deploy growth capital into the same companies.
Does Indaco Capital focus on specific technology sectors?
Specific sector concentrations are not publicly disclosed. The firm's mandate covers technology broadly, which in the Chinese context can include enterprise software, deep tech, AI applications, and digital platforms. Without published portfolio companies or stated vertical focuses, the firm's thesis is inferred from its early-stage, Beijing-based position in the market.
How is Indaco Capital structured, and who runs the firm?
The firm's registered name is Indaco Capital, with a headquarters in Beijing. Principal names and team composition have not been published on its website or in accessible regulatory filings. The firm operates as an asset manager, likely structured as a limited partnership with external LP capital, though fund-level detail is not confirmed.
Where does Indaco Capital source its deal flow?
In China's venture market, seed-stage deal flow typically comes directly from founder networks, university labs, and entrepreneur referrals rather than through investment banks or intermediaries. For a boutique Beijing-based manager like Indaco, sourcing is likely built on the principals' personal relationships with early-stage founders and the local tech ecosystem.
Does Indaco Capital lead rounds or participate alongside other investors?
The firm's lead-or-follow posture is not publicly documented. At seed stage in China, boutique managers often lead or co-lead rounds where check sizes are manageable, sometimes as the first institutional capital. Specific co-investment patterns, syndication preferences, or known co-investor relationships have not been disclosed by the firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: